Revolutionizing Ophthalmology Clinical Trials Through Enhanced Accessibility and Advanced AI-driven Analysis webinar replay

Revolutionizing Ophthalmology Clinical Trials Through Enhanced Accessibility and Advanced AI-driven Analysis

Clario and AliveCor collaborate to offer advanced, trial-focused six-lead ECG solutions for monitoring in decentralized clinical trials

Editorial: New Advanced Wireless Technologies for Objective Monitoring of Motor Symptoms in Parkinson’s Disease

eCOA Science Services

Expert guidance for capturing high-quality, regulatory compliant data from the right participants, at the right time, in clinic or at home. […]

Read More… from eCOA Science Services

Every Patient Matters: Bespoke Digital Endpoint Strategies for Rare Disease Drug Development

Clario and the University of Oxford’s NeuroMetrology Lab Advance Parkinson’s Disease Research with the Opal® Wearable Sensor System

Clario expands oncology trial support through collaboration with Radialogica to enhance radiation therapy quality control 

Applying a Holistic Digital Endpoint Strategy in the Development of Congestive Heart Failure Treatments Webinar Replay

Moving the Needle in Vaccine Trials: Optimizing Digital Endpoint and Operational Strategies to Enable Study Success

Definitive QT Evaluation – Clinical and Operational Considerations

DPHARM: Disruptive Innovations To Advance Clinical Research 2025

Applying a Holistic Digital Endpoint Strategy in the Development of Congestive Heart Failure Treatments

Dementias

Dementias, including Alzheimer’s disease affect millions worldwide and remain a major unmet need. Advancing treatment depends on accurate, reliable data in a field with complex, evolving endpoints.

Alzheimer’s Association International Conference (AAIC) 2025